Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Yang

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Journal of Affective Disorders|March 12, 2023
Assessing vaccine literacy and exploring its association with vaccine hesitancy: A validation of the vaccine literacy scale in ChinaLiuqing Yang, Shiqi Zhen, Lan Li, et al.
Environmental Science and Pollution Research International|April 3, 2024
Insight into the humification and carbon balance of biogas residual biochar amended co-composting of hog slurry and wheat strawYunpeng Liu, Junting Pan, Jingwen Wang, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteersGuoping Yang, Ranglang Huang, Shuang Yang, et al.
Expert Opinion on Investigational Drugs|September 16, 2022
Biosimilarity of HS-20090 to Denosumab in healthy Chinese subjects: a randomized, double-blinded, pharmacokinetics/pharmacodynamics studyYaqi Lin, Heng Yang, Xiaoyan Yang, et al.
Allergy|May 2, 2023
Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studiesXiaoyan Huang, Yi Xiao, Danrong Jing, et al.
Clinical Drug Investigation|May 2, 2022
Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese SubjectsQian Xiang, Zhiyan Liu, Guangyan Mu, et al.
Research and Practice in Thrombosis and Haemostasis|February 12, 2026
Safety, tolerability, pharmacokinetics, and pharmacodynamics of KN060, a humanized anti-FXI/FXIa dual-domain antibody, following single ascending doses in healthy Chinese subjectsJie Huang, Jinlong Liu, Yaxin Liu, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Hepatology (Baltimore, Md.)|November 2, 2017
Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathwayYao Lu, Zhou Jiang, Haijiang Dai, et al.
Drug Design, Development and Therapy|August 9, 2023
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese SubjectsJunlong Ma, Jie Huang, Chan Zou, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Journal of Affective Disorders|March 12, 2023
Assessing vaccine literacy and exploring its association with vaccine hesitancy: A validation of the vaccine literacy scale in ChinaLiuqing Yang, Shiqi Zhen, Lan Li, et al.
Environmental Science and Pollution Research International|April 3, 2024
Insight into the humification and carbon balance of biogas residual biochar amended co-composting of hog slurry and wheat strawYunpeng Liu, Junting Pan, Jingwen Wang, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteersGuoping Yang, Ranglang Huang, Shuang Yang, et al.
Expert Opinion on Investigational Drugs|September 16, 2022
Biosimilarity of HS-20090 to Denosumab in healthy Chinese subjects: a randomized, double-blinded, pharmacokinetics/pharmacodynamics studyYaqi Lin, Heng Yang, Xiaoyan Yang, et al.
Allergy|May 2, 2023
Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studiesXiaoyan Huang, Yi Xiao, Danrong Jing, et al.
Clinical Drug Investigation|May 2, 2022
Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese SubjectsQian Xiang, Zhiyan Liu, Guangyan Mu, et al.
Research and Practice in Thrombosis and Haemostasis|February 12, 2026
Safety, tolerability, pharmacokinetics, and pharmacodynamics of KN060, a humanized anti-FXI/FXIa dual-domain antibody, following single ascending doses in healthy Chinese subjectsJie Huang, Jinlong Liu, Yaxin Liu, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Hepatology (Baltimore, Md.)|November 2, 2017
Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathwayYao Lu, Zhou Jiang, Haijiang Dai, et al.
Drug Design, Development and Therapy|August 9, 2023
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese SubjectsJunlong Ma, Jie Huang, Chan Zou, et al.
Pageof 23